REMEGEN (09995): As of the end of July, a total of 13,000 A-shares have been repurchased.

20:02 03/08/2026

Rongchang Biological (09995) announced that as of July 31, 2026, the company has repurchased a total of 13,000 shares through the Shanghai Stock Exchange trading system via centralized bidding, accounting for 0.0023% of the company's total share capital. The highest repurchase price was 109.99 yuan per share, the lowest price was 109.00 yuan per share, and the total funds paid amounted to 1.428 million yuan (excluding transaction commissions and other trading fees).

REMEGEN (09995) announced that as of July 31, 2026, the company has repurchased a total of 13,000 shares through the Shanghai Stock Exchange trading system via centralized bidding, accounting for 0.0023% of the company's total share capital. The highest repurchase price was 109.99 yuan/share, and the lowest price was 109.00 yuan/share, with a total payment of 1.428 million yuan (excluding transaction commissions and other trading fees).

The demand for AI infrastructure is strong! KKR (KKR.US) has successfully raised a record $19.2 billion for its infrastructure fund, fully betting on data centers and energy transformation.

CIPRUN TECH (01020) has issued 180 million shares according to the share incentive plan.

Zhi Yuan discloses the board of directors and partners; the core team for the IPO is revealed for the first time.

The demand for AI infrastructure is strong! KKR (KKR.US) has successfully raised a record $19.2 billion for its infrastructure fund, fully betting on data centers and energy transformation.

CIPRUN TECH (01020) has issued 180 million shares according to the share incentive plan.

Zhi Yuan discloses the board of directors and partners; the core team for the IPO is revealed for the first time.